Fresh Concerns Raised About UIC Researcher’s Pediatric Drug Study

New documents reveal that Mani Pavuluri had enrolled her sons as controls in a prematurely halted drug trial, a ProPublica investigation finds.

Written byCatherine Offord
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Emails and other documents recently obtained by ProPublica Illinois have prompted fresh criticism of a famous pediatric psychiatrist whose work violated research rules and put children’s health at risk. University of Illinois at Chicago (UIC) researcher Mani Pavuluri, founder of a clinic to treat children with bipolar disorder, had enrolled her own sons as healthy controls in a clinical study of the therapeutic effects of lithium, ProPublica and The Chronicle of Higher Education report today (July 3).

There are ethical concerns about parents working with their own children in this way, “particularly [in] research that might be quite stressful for a child,” Michael Carome, a former senior official at the US Department of Health and Human Services (HHS) Office for Human Research Protections, tells ProPublica. “At a minimum, the researcher should not have done that without seeking approval from the [university’s institutional review board].”

Pavuluri’s study began in 2009 to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies